Connection

Milad Yazdani to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Milad Yazdani has written about Antibodies, Monoclonal, Humanized.
Milad Yazdani
Connection Strength
0.174
Antibodies, Monoclonal, Humanized
  1. Brain Lesion in the Setting of Chronic Rituximab Treatment. JAMA Oncol. 2020 07 01; 6(7):1093-1094.
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.